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Traditional concoctions sold in marketplaces are always assumed to be safe and eﬃcient; however, they can be potentially toxic
because of poor hygienic practices in plant processing or storage. The present study aimed to assess for the microbial quality of
market-sold vegetable drugs in Lom´ e. Thus, a total of 209 plant remedies were collected in marketplaces and analysed for the
presence of total aerobic bacteria, total coliforms, thermotolerant coliforms, Staphylococcus aureus, sulphite reducing bacteria,
and yeast and moulds according to the French Association of Normalisation (AFNOR) guidelines. The results revealed that
all formulations were contaminated by several microorganisms, excepted alcohol-based mixtures. According to AFNOR limits
nonconform drugs were according to total aerobic bacteria (86.96% powders, 81.82% capsules, 66.67% tisanes, and 42.11%
decoctions); to total coliforms (9.10% capsules, 8.70% powders and 1.75% decoction); to yeasts and moulds (77.78% ointments,
40% calcined powders, 36.36% capsules, and 23.91% powders). The microbiological analysis revealed that the majority of
contaminating bacteria were gram positive catalase positive and oxidase positive bacilli. Quality control studies on market-sold
remedies are currently needed to evaluate the microbial risk in consuming these products and they may allow the standardisation
of plant processing and storage.
1.Introduction
Plants have formed the basis of traditional medicine (TM)
that was used thousands years ago by humans. Until today
plant-based medicine continues to play a key role in health-
care systems in many regions worldwide, principally in
Africa where modern drugs are not aﬀordable. Indeed, it
has been estimated to 80% the percentage of people who
only rely on TM for their primarily health care in Africa
[1, 2]. Following leads supplied with traditional healers
(TH), many plants have been screened in laboratories for
biological activities. The majority of these studies conducted
in vitro or on animal models often showed scientiﬁc rational
behind plant usage with sometimes isolation of single pure
compoundsasactiveprinciple[3–5].However,thesesstudies
are focussed on plant extracts prepared by scientists after
collecting plant materials them self. The extractions are
made with organic solvents such as chloroform, methanol,
or ethanol; sometimes they make decoctions in accordance
with traditional practices [6–9]. Very few works have been
conducted on vegetable drugs directly provided by TH,
since the manufacturing of labelled and packaged herbal
concoctions with claims to cure diseases is still new in Africa.
The recipes and preparations are of TM origin while the
packaging and presentations are western; of course they still
lack western safety and quality controls [10, 11].
Working on these drugs must be a new challenge for
many reasons. Using plants for medicinal purposes is a
question of tradition and culture in Africa; thus collecting,
processing, and applying plants or plant-based medication
hasbeenhandeddownfromgenerationtogeneration.Tradi-
tional medicines with medicinal plants as their most impor-
tant components are sold in market places or prescribed
by TH in their homes [12, 13]. The physical conditions
and infrastructure in these markets are generally poor, with
most plant material displayed in the open. Under these2 Biotechnology Research International
conditions, the material is exposed to microbial and insect
attack as well as the eﬀects of light, gases, and temperature.
Often, these informal markets are situated close to both
pedestrian and motor vehicle traﬃc, which places plant
material in contact with various kinds of pollution [14]. The
main problem with these drugs is their hygienic quality in
three key regards: healers often collect plant material around
or in bushes near habitations and prepare drugs without
any preliminary treatment to eliminate indigenous microbes
sometimes, plant processing is carried out in their homes
in nonadequate hygienic conditions, and prepared drugs are
stored in inappropriate conditions. Overall, the ﬁnal product
proposed to the patients is sometimes of poor hygienic
quality [15].
The purpose of the present study was then to access for
the microbial quality of vegetable drugs sold in marketplaces
in Lom´ et o w n( T o g o ) .
2.MaterialandMethods
2.1.SamplesCollection. Drugsamplesanalysedinthepresent
study were collected from vegetable drug’s sellers in market-
places in Lom´ et o w no ra r o u n dL o m´ e( T o g o )f r o mM a r c ht o
June 2006. Afterwards, enquiries were made with available
drugs providers by oral questioning to access for plant
processing in particular plant materials collections, diagram
of drug preparations, and therapeutic indication of drugs if
not available on the packages.
2.2. Cell Enumeration. All media used in this study were
purchased from BioRad (France). For each sample, 10g
(for solid sample) or 10mL (for liquid sample) were mixed
with 90mL trypton-salt water (0.85% w/v) and stored at
ambient temperature for 45min. Afterwards, tenfold serial
dilutions were made for each suspension and 1mL diluted
suspension was used to inoculate speciﬁc culture media for
microbialisolationandenumerationasrecommendedbythe
French Association of Normalisation [16]. The total number
of microorganisms expressed as Colony Forming Unit (cfu)
per gram or per mL of sample was determined by standard
platecount.Thefollowingmicroorganismswereenumerated
under the following conditions.
(i) Total aerobic bacteria with Plate Count Agar (PCA)
after 24 hours incubation at 30
◦C.
(ii) Total coliforms and thermotolerant coliforms on
Violet Red Bile Lactose (VRBL) after 24 hours
incubation at 30 and 44
◦C, respectively.
(iii) Staphylococcus aureus by counting chapman coag-
ulase positive colonies after 24 hours incubation at
37
◦C.
(iv) Sulphite Reducing Bacteria (SRB) by Most Proba-
bly Number (MPN) with tryptone-sulﬁte neomycin
broth after 20 hours incubation at 44
◦C.
(v) Yeast and moulds with Sabouraud-Cloranfenicol
after 3 to 5 days incubation at 30
◦C.
Microbial quality of drugs was assayed using the critical
limits of French Association of Normalisation (AFNOR).
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Figure 1: Diagram of plant material processing.
Catalase test was performed by adding hydrogen peroxide
on a single colony. The presence of catalase was revealed by
the formation of gas bubbles. Oxidase tests were performed
usingavailablecommercialoxidasediskspurchasedfromBio
Rad (France).
3. Results
3.1. Formulations and Therapeutic Indications. At o t a lo f
209 products were collected in marketplaces in Lom´ e
town and in markets around the town. The drugs were
presented in several formulations including decoctions,
powders, capsules, ointments, soaps, alcohol-based mixtures
(ABM), honey-based mixtures (HBM), calcined powders,
and tisanes. Overall, decoctions formulations were most
r e p r e s e n t e df o l l o w e db yp o w d e r sa n do i n t m e n t s( Table 1).
Drugs were packed in bottles or in plastic sachets. Original
packageswithprintedtherapeuticindicationsandexpiration
datesaccountedfor15%(31/209)ofdrugs.Theothers(85%)
were in recovered packages with therapeutic indications orBiotechnology Research International 3
Table 1: Formulations of market-sold remedies in Lom´ e.
Formulations Percentages
Decoctions 27.27
Powders 22.01
Ointment 16.75
Alcohol-based mixtures 7.66
Soaps 7.66
Capsules 5.26
Calcined powders 4.79
Tisanes 4.79
Honey-based mixtures 4.30
Total number 209
without any information. In this case, therapeutic indica-
tionswereorallyprovidedbytheseller.Anotherconcernwith
theses remedies was that, the ingredients and their relative
quantities were not listed on the product label. This was
always kept as a secret for the TH.
Drugswereassumedtocuremanydiseasesasindicatedin
Table 2. According to the table, microbial infections, sexual
weakness, dermatitis, hypertension, and malaria were the
most cited.
3.2. Plant Materials Processing. Enquiries with drug pro-
viders allowed accessing for the general procedure in drug
preparation (Figure 1). Globally, plants materials were col-
lected around habitations or in bushes and the healers
only relied on their own experience in plant identiﬁcation.
Collected samples were processed in 5 steps including the
cleaning and the washing, the cutting of the plant materials
into small slices and the drying of the slices. Afterwards
the treatment may diﬀer according to the TH and the
formulation of the product. The dried slices could be directly
used as tisane, but for the other formulations the dried slices
were ground in a mortar prior further processing.
(i) Powders and capsules: the ground plant materials are
mixed with other substances of mineral or animal
origin and the mixture can then be manually or
semimanually packed in capsules or directly packed
in bottles or in sachet and ready for use.
(ii) Calcined powders: the slices are calcined in a pot
until darkness. The calcine is cooled with water and
ground in a mortar. For use, many of theses powders
are often dissolved in “sodabi,” local liquor distilled
from palm wine.
(iii) Honey-based mixture: this is prepared by adding the
vegetable powder directly on the honey.
(iv) Soaps are prepared with vegetable or animal oil. The
oil is boiled with vegetable powder until complete
homogenisation of the mixture. The mixture is
then ﬁltered and mixed with sodium hydroxide or
potassium hydroxide and boiled before cooling at
room temperature in their packages.
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Figure 2: Microbial contamination of market-sold remedies. Dec:
Decoctions, Pow: Powders, Oin: Ointments, ABM: Alcohol-Based
Mixtures, Cap: Capsules, Soa: Soaps, CP: Calcined powders, HBM:
Honey-Based Mixtures, Tis: Tisanes.
(v) Ointments: the ground plant materials are mixed
with melted shea butter or Vaseline colorant or
essential oil can be added to the mixture and the
product can be distributed in packages or stored.
(vi) Decoctions: the dried slices from single plant or plant
mixture are boiled together with other products of
animal origin or minerals. The boiling may take 1
to 12 hours according to TH or to products. After
cooling in air to ambient temperature the product is
packed in bottles or stored in drums.
(vii) ABM: local liquor distilled from palm wine and often
called “sodadi” is added to the dried slices in bottles
the mixture is allowed to stay for 15 to 30 days before
use.
Microbial quality was assayed for all the 209 collected
drugs. The following microorganisms were enumerated:
total aerobic bacteria, total coliforms and thermotolerant
coliforms, S. aureus, SRB, yeast, and moulds. According to
our results, neither S. aureus nor BSR were found in the
analysed products. For the other microorganisms, excepted
AMB, all the formulations were contaminated. The drugs
were much contaminated by total aerobic microorganisms.
Gram staining, catalase, and oxidase tests made on these
microorganisms revealed that they were essentially gram
positive, catalase positive, and oxidase bacilli. Total coliforms
were found to occur in decoctions, powders, and capsules.
Moulds and yeasts occurred in all formulations excepted
tisanes and ABM. In accordance with the ARNOR lim-
its, only ABM was conform according to all enumerated
microorganisms. The conformity of the other drugs varied
according to microorganisms. Figure 2 displays the percent-
ages of nonconform drugs as a function of microorganisms.
The majority of nonconform drugs were according to total
aerobic bacteria: 86.96% powders, 81.82% capsules, 66.67%
tisanes, and 42.11% decoctions. Yeast and moulds were the
second agent of nonconformity of the products indeed, 40%4 Biotechnology Research International
Table 2: Therapeutic indications of market-sold remedies in Lom´ e.
Dec Pow Soa ABM Cap Soa HBM CP Tis Total
Malaria 8 8 — — — — 1 — 6 15
Microbial infections 11 5 8 11 1 — — 5 3 44
Dermatitis 1 — 6 — — 12 — — — 19
Haemorrhoids 3 3 — — — — — — — 6
Sexual weaknesses 12 15 — — 5 — 4 — — 36
Anaemia 4 — — — — — 4 — — 8
Hypertension 7 5 — 5 — — — — — 17
Diabetes 2 1 — — — — — — — 3
Intestinal parasites 13 — — — — — — 1 — 14
Candidiasis — 1 3 — — — 4 — — 8
Hepatitis — 4 — 2 — — — — — 6
Sickles cell — — — — 1 — — — — 1
Dracunculosis — — 5 — — — — — — 5
Dec: Decoctions, Pow: Powders, Oin: Ointments, ABM: Alcohol-based mixtures, Cap: Capsules, Soa: Soaps, CP: Calcinated Powders, HBM: Honey-based
mixture, Tis: Tisanes, Hyp: Hypertension.
calcined powders, 36.36% capsules, and 23.91% powders
were not conform according to these germs.
4. Discussion
The present study aimed to assess for the microbial quality of
several vegetable drugs sold in Lom´ et o w ni no r d e rt oe v a l u -
ate the microbial risk in consuming these products. As many
other countries in Africa, Togolese government recognises
the importance of TM as a key provider of primary health-
care and is promoting the integration of traditional healing
into the oﬃcial health care system. However, treatment with
traditional remedies may expose the patients to three major
risks: the ineﬃcacy of the remedy to cure the disease, the
poisoning by toxic compound occurring in plant materials,
and the poisoning by microbial toxins, or microorganisms
occurring in poor hygienic quality remedies [17]. Nowadays,
much eﬀort is being made by scientists in solving the two
ﬁrst problems through biological screenings of plant extracts
for biological activities in vitro or on animal models [18, 19].
The main problem remains the poisoning by contaminating
microorganisms or their toxins in plant products.
Contamination by microbial pathogen may occur in
plant processing or during the storage [15]. The results
of the present study revealed that the traditional remedies
sold in Lom´ e marketplaces are contaminated by microbial
pathogens; however, S. aureus and SRB were not detected
in the drugs. The interest in detecting these two microor-
ganisms is that S. aureus is the leading species of the
genus Staphylococcus implicated in food poisoning infection.
SRB are a group anaerobic sporulating bacteria including
Clostridium, their spores resist after heat treatment and may
cause damages after contaminated product consumption.
Excepted ABM, contamination by total aerobic bacteria
occurred for all formulations including decoctions which
were also contaminated by total coliforms indicating faecal
origin contamination. Since decoctions passed by a boiling
step, their contamination occurred after the processing. In
fact, some TH often prepare their drug in poor environmen-
talconditionsandstoretheirdrugsinnonsterilebottlesaswe
remarked in our enquiries. Of course powders which do not
pass by a heating step are more contaminated. Elimination
of yeasts and mould from foods and other products remains
diﬃcult because they produce thermoresistant spore that
survive heat treatment. Indeed our results indicated that
all formulations were contaminated by yeast and mould
excepted ABM and tisanes. The main risk with theses
microorganisms is the fact that some strains can elaborate
mycotoxins occasioning poisoning.
Despite microbial contamination of market-sold tradi-
tional remedies, expiration dates could also be pointed out.
In our enquiries many healers did not mention expiration
date of their products. The ones who provided it only relied
on empirical observations. It is evident that the biolog-
ical activity of plant extract is time-dependent, phenolic
compounds are the main examples. They are vulnerable to
polymerization through air oxidization. High polymeriza-
tion results in insoluble complex that precipitate in solution.
This oxidization may ﬁrst aﬀect the extractability of the
phenolic compounds that is crucial in drug preparation; in
this topic some authors suggested extracting the compounds
directly on fresh material in order to enhance the yield
[20]. Secondly, an important factor governing the activity of
phenolic compounds is their polymerization size. Oxidized
condensation of phenols may result in the toxiﬁcation of
microorganisms, while the adverse eﬀects can be observed
in some cases [21–23]. Storage and drying process may then
aﬀect the chemical composition of the material. It is useful
to use fresh material rather than dried material but this is
the form which is usually preferred by traditional healers
[24]. In accordance with these observations relying only on
empirical observations to estimate expiration date is not theBiotechnology Research International 5
adequate way. In addition, TH rely on empirical experience
in the plant identiﬁcation, there also remains a major risk of
misidentiﬁcation.
The lack of quality control and regulations on standard-
isation of natural products may result in varying concentra-
tions of active compounds, consumption of contaminants
such as microbes or their microbial toxins, heavy metals, and
possible fatal side eﬀects as a result of misidentiﬁcation of
plant material. In addition, convincing TH to reveal their
ingredients as well as the recipes of their products as it is a
guarded secret amongst them still remains a challenge.
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